Neogen (NEOG) Liabilities from Discontinued Operations (2025 - 2026)
Neogen (NEOG) recorded quarterly Liabilities from Discontinued Operations of 6400000.0 in Q1 2026, down 29.72% quarter-over-quarter from 9107000.0 in Q4 2025.
Neogen (NEOG) Liabilities from Discontinued Operations (2025 - 2026) Analysis & Trends
Neogen's Liabilities from Discontinued Operations history runs 2 years deep, the most recent figure standing at 6400000.0 for Q1 2026.
- In Q1 2026, Liabilities from Discontinued Operations changed N/A year-over-year to 6400000.0; the TTM figure through Feb 2026 stood at 6400000.0 (changed N/A YoY), while the FY2025 annual figure was 6600000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations was 6400000.0 for Q1 2026 at Neogen, down from 9107000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 9107000.0 in Q4 2025 to a low of 6400000.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 6.40 Mn |
| Feb 28, 2026 | 6.40 Mn |
| Nov 30, 2025 | 9.11 Mn |
| Nov 30, 2025 | 9.11 Mn |
| May 31, 2025 | 6.60 Mn |
| May 31, 2025 | 6.60 Mn |